A Time-to-Event Model for Acute Renal Failure in Sirolimus and Tacrolimus-Based Graft-Versus-Host Disease Prophylaxis for Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

被引：0

作者：

Luis Pinana, Jose ^{[1
,2
]}

Perez-Pitarch, Alejandro ^{[3
]}

Garcia-Cadenas, Irene ^{[4
]}

Barba, Pere ^{[5
]}

Hernandez-Boluda, Juan-Carlos ^{[6
]}

Laura Fox, Maria ^{[5
]}

Jose Terol, Maria ^{[6
]}

Maria Queralto, Josep ^{[7
]}

Vima, Jaume ^{[8
]}

Valcarcel, David ^{[5
]}

Ferriols-Lisart, Rafael ^{[3
]}

Sierra, Jorge ^{[4
]}

Martino, Rodrigo ^{[4
]}

Solano, Carlos ^{[6
]}

机构：

[1] Hosp Univ & Politecn La Fe, Serv Hematol, Valencia, Spain

[2] Hosp Univ & Politecn La Fe, Dept Hematol, Valencia, Spain

[3] Hosp Clin Univ, Dept Pharm, Valencia, Spain

[4] Univ Autonoma Barcelona, Dept Hematol, Hosp St Pau, Barcelona, Spain

[5] Univ Autonoma Barcelona, Dept Hematol, Hosp Vall dHebron, Barcelona, Spain

[6] Hosp Clin Univ, Dept Hematol, Fdn Invest INCLIVA, Valencia, Spain

[7] Hosp Santa Creu & Sant Pau, Dept Biochem, Barcelona, Spain

[8] Hosp Univ Vall DHebron, Dept Biochem, Barcelona, Spain

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2017年 / 23卷 / 03期

关键词：

D O I：

10.1016/j.bbmt.2016.12.207

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

402

引用

页码：S292 / S292

页数：1

共 50 条

[1] A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis
Luis Pinana, Jose
Perez-Pitarch, Alejandro
Garcia-Cadenas, Irene
Barba, Pere
Carlos Hernandez-Boluda, Juan
Esquirol, Albert
Laura Fox, Maria
Jose Terol, Maria
Queralto, Josep M.
Vima, Jaume
Valcarcel, David
Ferriols-Lisart, Rafael
Sierra, Jorge
Solano, Carlos
Martino, Rodrigo
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (07) : 1177 - 1185
[2] Sirolimus combined with tacrolimus as graft-versus-host disease prophylaxis after allogeneic stem cell transplantation
Mattsson, J.
Svenberg, P.
Gustafsson, B.
Remberger, M.
Ringden, O.
[J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S234 - S234
[3] A dynamic time-to-event model for prediction of acute graft-versus-host disease in patients after allogeneic hematopoietic stem cell transplantation
Och, Katharina
Turki, Amin T.
Goetz, Katharina M.
Selzer, Dominik
Brossette, Christian
Theobald, Stefan
Braun, Yvonne
Graf, Norbert
Rauch, Jochen
Rohm, Kerstin
Weiler, Gabriele
Kiefer, Stephan
Schwarz, Ulf
Eisenberg, Lisa
Pfeifer, Nico
Ihle, Matthias
Grandjean, Andrea
Fix, Sonja
Riede, Claudia
Rissland, Juergen
Smola, Sigrun
Beelen, Dietrich W.
Kaddu-Mulindwa, Dominic
Bittenbring, Joerg
Lehr, Thorsten
[J]. CANCER MEDICINE, 2024, 13 (01):
[4] Graft Versus Host Disease Prophylaxis with Tacrolimus, Sirolimus and MMF in Patients Undergoing Reduced Intensity Conditioning Allogeneic Transplantation
Lopez Corral, Lucia
Blazquez Goni, Cristina
Perez Lopez, Estefania
Martin Dominguez, Francisco Manuel
Cabero Martinez, Almudena
Rodriguez Torres, Nancy
Cabrero Calvo, Monica
Espigado, Ildefonso
Martin Lopez, Ana Africa
Parody, Rocio
Baile Gonzalez, Monica
Caballero, Teresa
Cortes-Rodriguez, Maria
Soria Saldise, Elena
Avendano Pita, Alejandro
Alcalde Mellado, Patricia
Garcia Bacelar, Ana
Rodriguez Arboli, Eduardo
Lopez Parra, Miriam
Francisco Falantes, Jose
Navarro Bailon, Almudena
Vazquez Lopez, Lourdes
Escamilla Gomez, Virginia
Martin, Fermin Sanchez-Guijo
Perez-Simon, Jose A.
[J]. BLOOD, 2023, 142
[5] Outcomes Following Intolerance to Tacrolimus/Sirolimus Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation
Mirza, Abu-Sayeef
Tandon, Ankita
Jenneman, Dakota
Cao, Shu
Brimer, Thomas
Kumar, Ambuj
Kidd, Michelle
Khimani, Farhad
Faramand, Rawan
Mishra, Asmita
Liu, Hien
Nishihori, Taiga
Perez, Lia
Lazaryan, Aleksandr
Bejanyan, Nelli
Nieder, Michael
Anasetti, Claudio
Pidala, Joseph
Elmariah, Hany
[J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (04): : 185.e1 - 185.e7
[6] Outcomes Following Intolerance to Tacrolimus/Sirolimus for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant
Mirza, Sayeef
Tandon, Ankita
Jenneman, Dakota
Cao, Shu
Kumar, Ambuj
Kidd, Michelle R.
Khimani, Farhad
Mishra, Asmita
Liu, Hien D.
Nishihori, Taiga
Perez, Lia
Bejanyan, Nelli
Pidala, Joseph
Nieder, Michael
Elmariah, Hany
[J]. BLOOD, 2019, 134
[7] Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning
Armand, Philippe
Gannamaneni, Supriya
Kim, Haesook T.
Cutler, Corey S.
Ho, Vincent T.
Koreth, John
Alyea, Edwin P.
LaCasce, Ann S.
Jacobsen, Eric D.
Fisher, David C.
Brown, Jennifer R.
Canellos, George P.
Freedman, Arnold S.
Soiffer, Robert J.
Antin, Joseph H.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (35) : 5767 - 5774
[8] Improved Outcomes Using Tacrolimus/Sirolimus for Graft-versus-Host Disease Prophylaxis with a Reduced-Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant as treatment of Myelofibrosis
Snyder, David S.
Palmer, Joycelynne
Gaal, Karl
Stein, Anthony S.
Pullarkat, Vinod
Sahebi, Firoozeh
Vora, Nyana
Nakamura, Ryotaro
Forman, Stephen J.
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : 281 - 286
[9] Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation
Mohty, M
de Lavallade, H
Faucher, C
Bilger, K
Vey, N
Stoppa, AM
Gravis, G
Coso, D
Viens, P
Gastaut, JA
Blaise, D
[J]. BONE MARROW TRANSPLANTATION, 2004, 34 (06) : 527 - 530
[10] Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation
M Mohty
H de Lavallade
C Faucher
K Bilger
N Vey
A-M Stoppa
G Gravis
D Coso
P Viens
J-A Gastaut
D Blaise
[J]. Bone Marrow Transplantation, 2004, 34 : 527 - 530

← 1 2 3 4 5 →